{"identifier":"/us/usc/t21/s1523","title_num":"21","num":"§ 1523.","heading":"Definitions","status":null,"guid":"id41d07c91-a3d3-11e9-95d4-f3ff9237185e","source_credit":"(Pub. L. 100–690, title I, § 1023, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 225; amended Pub. L. 115–271, title VIII, § 8203(b)(2), Oct. 24, 2018, 132 Stat. 4111.)","seq_in_title":623,"parent_identifier":"/us/usc/t21/ch20/schII","ancestors":[{"identifier":"/us/usc/t21","level":"title","num":"Title 21—","heading":"FOOD AND DRUGS","status":null,"is_section":false},{"identifier":"/us/usc/t21/ch20","level":"chapter","num":"CHAPTER 20—","heading":"NATIONAL DRUG CONTROL PROGRAM","status":null,"is_section":false},{"identifier":"/us/usc/t21/ch20/schII","level":"subchapter","num":"SUBCHAPTER II—","heading":"DRUG-FREE COMMUNITIES","status":null,"is_section":false}],"xml":"<section xmlns=\"http://xml.house.gov/schemas/uslm/1.0\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xmlns:dc=\"http://purl.org/dc/elements/1.1/\" xmlns:dcterms=\"http://purl.org/dc/terms/\" style=\"-uslm-lc:I80\" id=\"id41d07c91-a3d3-11e9-95d4-f3ff9237185e\" identifier=\"/us/usc/t21/s1523\"><num value=\"1523\">§ 1523.</num><heading> Definitions</heading>\n<chapeau style=\"-uslm-lc:I11\" class=\"indent0\">In this subchapter:</chapeau><paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"id41d07c92-a3d3-11e9-95d4-f3ff9237185e\" identifier=\"/us/usc/t21/s1523/1\"><num value=\"1\" class=\"bold\">(1)</num><heading class=\"bold\"> Administrator</heading><content><p style=\"-uslm-lc:I12\" class=\"indent1\">The term “Administrator” means the Administrator appointed by the Director under <ref href=\"/us/usc/t21/s1531/c\">section 1531(c) of this title</ref>.</p>\n</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"id41d07c93-a3d3-11e9-95d4-f3ff9237185e\" identifier=\"/us/usc/t21/s1523/2\"><num value=\"2\" class=\"bold\">(2)</num><heading class=\"bold\"> Advisory Commission</heading><content><p style=\"-uslm-lc:I12\" class=\"indent1\">The term “Advisory Commission” means the Advisory Commission established under section 1541 <ref class=\"footnoteRef\" idref=\"fn002156\">1</ref><note type=\"footnote\" id=\"fn002156\"><num>1</num> See References in Text note below.</note> of this title.</p>\n</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"id41d07c94-a3d3-11e9-95d4-f3ff9237185e\" identifier=\"/us/usc/t21/s1523/3\"><num value=\"3\" class=\"bold\">(3)</num><heading class=\"bold\"> Community</heading><content><p style=\"-uslm-lc:I12\" class=\"indent1\">The term “community” shall have the meaning provided that term by the Administrator, in consultation with the Advisory Commission.</p>\n</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"id41d07c95-a3d3-11e9-95d4-f3ff9237185e\" identifier=\"/us/usc/t21/s1523/4\"><num value=\"4\" class=\"bold\">(4)</num><heading class=\"bold\"> Director</heading><content><p style=\"-uslm-lc:I12\" class=\"indent1\">The term “Director” means the Director of the Office of National Drug Control Policy.</p>\n</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"id41d07c96-a3d3-11e9-95d4-f3ff9237185e\" identifier=\"/us/usc/t21/s1523/5\"><num value=\"5\" class=\"bold\">(5)</num><heading class=\"bold\"> Eligible coalition</heading><content><p style=\"-uslm-lc:I12\" class=\"indent1\">The term “eligible coalition” means a coalition that meets the applicable criteria under <ref href=\"/us/usc/t21/s1532/a\">section 1532(a) of this title</ref>.</p>\n</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"id41d07c97-a3d3-11e9-95d4-f3ff9237185e\" identifier=\"/us/usc/t21/s1523/6\"><num value=\"6\" class=\"bold\">(6)</num><heading class=\"bold\"> Grant recipient</heading><content><p style=\"-uslm-lc:I12\" class=\"indent1\">The term “grant recipient” means the recipient of a grant award under <ref href=\"/us/usc/t21/s1532\">section 1532 of this title</ref>.</p>\n</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"id41d07c98-a3d3-11e9-95d4-f3ff9237185e\" identifier=\"/us/usc/t21/s1523/7\"><num value=\"7\" class=\"bold\">(7)</num><heading class=\"bold\"> Nonprofit organization</heading><content><p style=\"-uslm-lc:I12\" class=\"indent1\">The term “nonprofit organization” means an organization described under <ref href=\"/us/usc/t26/s501/c/3\">section 501(c)(3) of title 26</ref> that is exempt from taxation under <ref href=\"/us/usc/t26/s501/a\">section 501(a) of title 26</ref>.</p>\n</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"id41d07c99-a3d3-11e9-95d4-f3ff9237185e\" identifier=\"/us/usc/t21/s1523/8\"><num value=\"8\" class=\"bold\">(8)</num><heading class=\"bold\"> Program</heading><content><p style=\"-uslm-lc:I12\" class=\"indent1\">The term “Program” means the program established under <ref href=\"/us/usc/t21/s1531/a\">section 1531(a) of this title</ref>.</p>\n</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"id41d07c9a-a3d3-11e9-95d4-f3ff9237185e\" identifier=\"/us/usc/t21/s1523/9\"><num value=\"9\" class=\"bold\">(9)</num><heading class=\"bold\"> Substance use and misuse</heading><chapeau>The term “substance use and misuse” means—</chapeau><subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"id41d07c9b-a3d3-11e9-95d4-f3ff9237185e\" identifier=\"/us/usc/t21/s1523/9/A\"><num value=\"A\">(A)</num><content> the illegal use or misuse of drugs, including substances for which a listing is effect <ref class=\"footnoteRef\" idref=\"fn002157\">2</ref><note type=\"footnote\" id=\"fn002157\"><num>2</num> So in original.</note> under any of schedules I through V under <ref href=\"/us/usc/t21/s812\">section 812 of this title</ref>;</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"id41d07c9c-a3d3-11e9-95d4-f3ff9237185e\" identifier=\"/us/usc/t21/s1523/9/B\"><num value=\"B\">(B)</num><content> the misuse of inhalants or over-the-counter drugs; or</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"id41d07c9d-a3d3-11e9-95d4-f3ff9237185e\" identifier=\"/us/usc/t21/s1523/9/C\"><num value=\"C\">(C)</num><content> the use of alcohol, tobacco, or other related product as such use is prohibited by State or local law.</content>\n</subparagraph>\n</paragraph>\n<paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"id41d07c9e-a3d3-11e9-95d4-f3ff9237185e\" identifier=\"/us/usc/t21/s1523/10\"><num value=\"10\" class=\"bold\">(10)</num><heading class=\"bold\"> Youth</heading><content><p style=\"-uslm-lc:I12\" class=\"indent1\">The term “youth” shall have the meaning provided that term by the Administrator, in consultation with the Advisory Commission.</p>\n</content>\n</paragraph>\n<sourceCredit id=\"id41d07c9f-a3d3-11e9-95d4-f3ff9237185e\">(<ref href=\"/us/pl/100/690/tI/s1023\">Pub. L. 100–690, title I, § 1023</ref>, as added <ref href=\"/us/pl/105/20/s2/a/2\">Pub. L. 105–20, § 2(a)(2)</ref>, <date date=\"1997-06-27\">June 27, 1997</date>, <ref href=\"/us/stat/111/225\">111 Stat. 225</ref>; amended <ref href=\"/us/pl/115/271/tVIII/s8203/b/2\">Pub. L. 115–271, title VIII, § 8203(b)(2)</ref>, <date date=\"2018-10-24\">Oct. 24, 2018</date>, <ref href=\"/us/stat/132/4111\">132 Stat. 4111</ref>.)</sourceCredit>\n<notes type=\"uscNote\" id=\"id41d07ca0-a3d3-11e9-95d4-f3ff9237185e\">\n<note style=\"-uslm-lc:I75\" topic=\"referencesInText\" id=\"id41d07ca1-a3d3-11e9-95d4-f3ff9237185e\">\n<heading class=\"centered smallCaps\">References in Text</heading><p style=\"-uslm-lc:I21\" class=\"indent0\"><ref href=\"/us/usc/t21/s1541\">Section 1541 of this title</ref>, referred to in par. (2), was repealed by <ref href=\"/us/pl/115/271/tVIII/s8203/b/5\">Pub. L. 115–271, title VIII, § 8203(b)(5)</ref>, <date date=\"2018-10-24\">Oct. 24, 2018</date>, <ref href=\"/us/stat/132/4112\">132 Stat. 4112</ref>.</p>\n</note>\n<note style=\"-uslm-lc:I74\" topic=\"amendments\" id=\"id41d07ca2-a3d3-11e9-95d4-f3ff9237185e\"><heading class=\"centered smallCaps\">Amendments</heading><p style=\"-uslm-lc:I21\" class=\"indent0\">2018—Par. (9). <ref href=\"/us/pl/115/271\">Pub. L. 115–271</ref>, which directed adding par. (9) and striking out former par. (9), which defined “substance abuse”, in section 1023 of “chapter 2 of subtitle A of title I of the National Narcotics Leadership Act of 1988”, was executed to this section, which is section 1023 of chapter 2 of the National Narcotics Leadership Act of 1988, to reflect the probable intent of Congress. The National Narcotics Leadership Act of 1988 is itself subtitle A of title I of <ref href=\"/us/pl/100/690\">Pub. L. 100–690</ref>.</p>\n</note>\n</notes>\n</section>","provision":null,"duplicates":[],"release":{"label":"116-29","currency_date":"2019-07-05","congress":116,"law_num":29,"excluded_laws":[],"update_num":null,"seq":177,"is_partial":false,"caveat":null,"titles_affected":["02","06","07","15","16","19","21","26","34","38","42","43","48","49","50"],"ingested_titles":[]},"served_from":{"label":"116-29","currency_date":"2019-07-05","congress":116,"law_num":29,"excluded_laws":[],"update_num":null,"seq":177,"is_partial":false,"caveat":null,"titles_affected":["02","06","07","15","16","19","21","26","34","38","42","43","48","49","50"],"ingested_titles":[]},"content_first_seen":{"label":"116-29","currency_date":"2019-07-05","congress":116,"law_num":29,"excluded_laws":[],"update_num":null,"seq":177,"is_partial":false,"caveat":null,"titles_affected":["02","06","07","15","16","19","21","26","34","38","42","43","48","49","50"],"ingested_titles":[]},"is_exact":true,"note":null}